✦ LIBER ✦

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

✍ Scribed by D Katinger, A Wagner, I Luque, S Crespillo, F Conejero-Lara, M Roger…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a prototype

✍ Shahida Baqar; A.Louis Bourgeois; Peter J. Schultheiss; Richard I. Walker; David 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 963 KB

Safety and immunogenicity of inactivated

✍ Wendy A. Keitel; Cornelia L. Dekker; ChrisAnna Mink; James D. Campbell; Kathryn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Immunogenicity, reactogenicity and safet

✍ D.D. Anh; C.C. Carlos; D.V. Thiem; Y. Hutagalung; S. Gatchalian; H.L. Bock; I. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Immunogenicity and safety in adults of o

✍ François Roman; Tejaswini Vaman; Beatrice Gerlach; Andre Markendorf; Paul Gillar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 143 KB